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Abstract
Hippocampal plasticity (e.g. neurogenesis) likely plays an important role in maintaining addictive behavior and ⁄ or relapse. This study
assessed whether rats with differential propensity to drug-seeking behavior, bred Low-Responders (bLR) and bred High-Responders
(bHR) to novelty, show differential neurogenesis regulation after cocaine exposure. Using specific immunological markers, we
labeled distinct populations of adult stem cells in the dentate gyrus at different time-points of the cocaine sensitization process; Ki-67
for newly born cells, NeuroD for cells born partway, and 5-bromo-2¢-deoxyuridine for older cells born prior to sensitization. Results
show that: (i) bHRs exhibited greater psychomotor response to cocaine than bLRs; (ii) acute cocaine did not alter cell proliferation in
bLR ⁄ bHR rats; (iii) chronic cocaine decreased cell proliferation in bLRs only, which became amplified through the course of
abstinence; (iv) neither chronic cocaine nor cocaine abstinence affected the survival of immature neurons in either phenotype; (v)
cocaine abstinence decreased survival of mature neurons in bHRs only, an effect that paralleled the greater psychomotor response
to cocaine; and (vi) cocaine treatment did not affect the ratio of neurons to glia in bLR ⁄ bHR rats as most cells differentiated into
neurons in both lines. Thus, cocaine exerts distinct effects on neurogenesis in bLR vs. bHR rats, with a decrease in the birth of new
progenitor cells in bLRs and a suppression of the survival of new neurons in bHRs, which likely leads to an earlier decrease in
formation of new connections. This latter effect in bHRs could contribute to their enhanced degree of cocaine-induced psychomotor
behavioral sensitization.
Introduction
Cocaine is a highly abused drug that poses an enormous health,
social and economic toll on society. A major challenge of addiction
research is to identify factors that predispose individuals’ addiction in
order to develop novel and better-tailored treatment options. Our
laboratory has selectively bred Sprague–Dawley rats for high (High-
Responder, bHR) and low (Low-Responder, bLR) novelty-seeking
behavior, a trait that predicts a variety of differences in emotional
reactivity (Perez et al., 2009), including propensity to acquire cocaine
self-administration (Piazza et al., 1989; Piazza & Le Moal, 1996;
Davis et al., 2008) and behavioral sensitization (Hooks et al., 1991,
1992).
Drugs of abuse produce neuroadaptations in particular brain areas
implicated in reward and learning that likely underlie their long-lasting
effects (Robinson & Kolb, 2004; Kalivas, 2007). It is well known that
drugs of abuse such as cocaine are rewarding by virtue of their ability
to increase dopamine concentrations in ventral tegmental area
projections, such as the nucleus accumbens (NAc) (Gold et al.,
1989). However, beyond modulating specific transmitter systems,
initial propensity to drug abuse (i.e. bLR vs. bHR rats) may have more
to do with environmental reactivity and stress responsiveness at other
anatomical levels. In particular, the hippocampus (HC), which is
highly interconnected with limbic structures that regulate mood and
cognition, can influence the learning component of addiction and is
associated with many psychostimulant effects, including contextual
conditioning (Shen et al., 2006) and behavioral sensitization (Lodge
& Grace, 2008). Indeed, neonatal lesions of the ventral HC produced
enhanced cocaine sensitization in adulthood (Chambers & Taylor,
2004), providing a direct association between sensitization and altered
hippocampal (HCal) circuits. Moreover, some of the known
bLR ⁄ bHR neuroadaptations that may contribute to their drug-taking
differences occur in the HC (Maccari et al., 1991; Kabbaj et al., 2000;
Turner et al., 2008).
Adult neurogenesis represents one form of HCal plasticity that may
contribute to the brain’s ability to process, adapt and respond to stimuli
(e.g. brain dysfunction in drug addiction). Adult HCal neurogenesis is
a highly dynamic process where mature functionally integrated
granular neurons are generated from progenitor cells in the dentate
gyrus (DG) (Ming & Song, 2005). Each stage of neurogenesis is
demarcated by distinct molecular markers (von Bohlen Und Halbach,
2007) and is regulated by a variety of factors, including adverse
environmental conditions (Schmidt & Duman, 2007) and exposure to
addictive substances (Eisch & Harburg, 2006). Particularly, experi-
menter-administered cocaine impaired cell proliferation in adult rat
HC (Yamaguchi et al., 2004) without altering the survival and growth
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of immature cells (Dominguez-Escriba et al., 2006), suggesting
that cocaine differentially modulates cells at different stages of
neurogenesis. Thus, altered neurogenesis represents one drug-regu-
lated form of neuroplasticity that may contribute to the maintenance of
addictive behavior and ⁄ or relapse.
Against this background, the present study attempts to understand
how experimenter-administered cocaine may alter the cellular com-
position of the HC in an animal model of differential propensity to
drug abuse (bLR ⁄ bHR rats), and to ascertain which stages of adult
HCal neurogenesis (e.g. cell proliferation, survival, differentiation)
may be regulated by cocaine within each phenotype.
Materials and methods
Experimental design, animals and drug treatment
The first part of the study (Study I) characterized the bLR ⁄ bHR animal
model of differential propensity to drug abuse to examine their
behavioral responses to novelty (i.e. what defines the phenotype) and
cocaine (i.e. different psychomotor response to cocaine). Once the
animal model was well defined, the second part of the study (Study II)
assessed the impact of cocaine on adult HCal neurogenesis in
bLR ⁄ bHR rats. The experimental design, animals used and drug
treatments are described in detail below.
Study I: characterization of bLR and bHR rats
bLR ⁄ bHR differences in locomotor response to novelty
For the last several years our laboratory has selectively bred rats (bLR
and bHR lines) on the basis of locomotor reactivity to a novel
environment, demonstrating reliable differences across multiple
behavioral and neurobiological dimensions. A description of the
breeding strategy and initial behavioral characterization of the bHR
and bLR lines was previously published (Stead et al., 2006) and has
been extended in the present study (see Results; Fig. 1).
Each generation of male rats was screened for locomotor activity at
about 60 days old (see Stead et al., 2006). Note that Fig. 1A
represents bLR and bHR rats’ inborn basal locomotor differences
from generations F1–F20, although the present studies only used rats
from generations F15 and F20. Horizontal and rearing activity was
monitored by computer in 5-min intervals over 60 min by placing
animals into clear acrylic 43 · 21.5 · 25.5 cm (high) cages equipped
with infrared photocell emitters mounted 2.3 and 6.5 cm above the
grid floor in a different room from where the animals had been housed.
The locomotion-testing rig and motion-recording software were
created in-house at the University of Michigan. All testing was
performed between 08:00 and 11:30 h. Final locomotion scores for
each rat were calculated by adding the total number of horizontal and
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Fig. 1. Characterizing the bred Low-Responder (bLR) ⁄ bred High-Responder (bHR) rat phenotype: selective breeding for novelty-seeking trait. (A) bLR ⁄ bHR
differences in locomotor response to novelty across generations (F1–F20). Differences in mean locomotion (total activity, which is the sum of lateral movement and
rearing, lateral movement, rearing) between bLR and bHR animals are shown for 20 generations of selective breeding (F1–F20). Mean locomotion scores diverge
dramatically between the two lines with increasing rounds of selection. All data are mean ± standard deviation. (B) bLR ⁄ bHR differences in psychomotor
sensitization to cocaine (F20). Experimental design: effects of chronic cocaine administration (15 mg ⁄ kg, i.p., 7 days) on locomotor activity on Days 1, 7 and 21 of
testing in bLR and bHR rats (7 bLR ⁄ bHR pairs). On testing days rats were habituated for 1 h to the locomotor cage before receiving cocaine. Locomotion (total,
lateral, rearing) was calculated for each rat as the locomotion scores after cocaine injection (stimulated) minus the background (last 30 min of habituation;
mean ± SEM; *P < 0.05).
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deviation below the bHR group average and bLR animals whose
scores fell one standard deviation above the group average were not
used for the subsequent cocaine treatment study. The present series of
studies used two sets of 25 bLR ⁄ bHR pairs from two different
generations (F15 and F20). Animals were treated in accordance with
the ethical guidelines of the University of Michigan Committee on the
Use and Care of Animals (UCUCA).
bLR ⁄ bHR differences in psychomotor sensitization to cocaine
It is known that in commercially available outbred LR ⁄ HR rats, the
animals’ reactivity to novelty predicts the degree of cocaine sensiti-
zation, with HR rats showing a greater psychomotor response to
cocaine than LRs (Hooks et al., 1992). Thus, the idea behind this
experiment was to extend these earlier findings showing that our
selectively-bred bLR ⁄ bHR rats also show differences in psychomotor
sensitization to cocaine.
For this purpose, following bLR ⁄ bHR phenotype characterization
(described above), we used 7 pairs of adult bLR and bHR males from
the 20th generation weighting 225–250 g (n = 7 per group). On the first
day of testing, rats were transferred from the colony room and placed
into the activity-monitoring chambers described above. Due to the
known bLR ⁄ bHR differences in motor activity, animals were allowed
to habituate for 1 h before receiving a cocaine injection (15 mg ⁄ kg,
i.p.; Fig. 1B), followed by 1 h during which locomotion (horizontal and
rearing activity) was scored. After the first day of testing rats were
returned to their home cages. Once a day for the next 6 days rats were
injected in an adjacent novel room with 15 mg ⁄ kg of cocaine (at about
10:00 h). On Day 7, rats were returned to the activity chambers where
they were again allowed to habituate before receiving a single cocaine
injection followed by 1 h behavioral scoring. After 14 days of
abstinence, rats were transferred to the activity chambers; following
1 h habituation animals were challenged with 15 mg ⁄ kg dose of
cocaine to assess its impact on locomotion for an additional hour.
For each rat we calculated locomotion scores (total, lateral and
rearing activity) as the value following cocaine injection (stimulated)
minus the background (defined as activity occurring during the last
30 min of habituation). This method allowed us to correct for the basal
inborn differences in bLR ⁄ bHR rats and to compare both groups
following cocaine treatments.
Study II: bLR ⁄ bHR differences in neurogenesis following
experimenter-administered cocaine
Once we characterized animals according to their bLR ⁄ bHR pheno-
type, the aim of the next study was to investigate potential differences
in adult HCal neurogenesis (recent cell proliferation, early and late cell
survival, and cell differentiation) following cocaine treatments. This
second study consisted of two sets of experiments detailed below. The
initial pilot study assessed the effect of cocaine on cell proliferation in
bLR ⁄ bHR rats, and later led to a second more complete study that
included neurogenesis regulation at different stages.
bLR ⁄ bHR differences in cell proliferation following
experimenter-administered cocaine
We used bLR and bHR rats (F15, n = 5 per phenotype per
experimental group) to determine the effects of acute, chronic and
early cocaine abstinence on adult HCal cell proliferation as measured
by Ki-67 immunohistochemistry (IHC) in the DG (Fig. 2A). The
chronic cocaine treatment is known to induce behavioral sensitization
Fig. 2. Bred Low-Responder (bLR) ⁄ bred High-Responder (bHR) differ-
ences in cell proliferation following experimenter-administered cocaine.
(A) bLR and bHR rats (F15, 25 pairs, n = 5 per group) were used to
determine the effects of acute, chronic and early cocaine abstinence on adult
HCal cell proliferation as measured by Ki-67 IHC in the DG. Groups of
treatment: vehicle (0.9% NaCl, i.p., 7 days); acute cocaine (acute, 6 days of
saline, and on Day 7 15 mg ⁄ kg of cocaine); chronic cocaine (15 mg ⁄ kg for
7 days); chronic cocaine followed by abstinence (3 days); and vehicle
abstinence control group. The pool of Ki-67-positive cells being labeled is
indicated by a rectangle coded for each treatment group and represents the
cells recently born in the last 25 h at the time of killing the animals (within
a cell cycle; Cameron & McKay, 2001). (B and C) Chronic cocaine
decreased cell proliferation only in bLR rats. Columns are means ± SEM per
group and expressed as Ki-67 cell number in the DG. The groups vehicle
and vehicle abstinence were pooled as a single control group due to no
significant Ki-67 cell number differences between them. *P < 0.05 acute vs.
chronic cocaine. Note that there is a 32 ± 11% decrease in Ki-67 cell
number when comparing vehicle with chronic cocaine, even though this
effect did not reach statistical significance.
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(Gosnell, 2005), and produces bLR ⁄ bHR differences in psychomotor
response to the drug (Fig. 1B). Thus, one group of bLR ⁄ bHR rats
received daily injections of 15 mg ⁄ kg cocaine (i.p.), whereas the
control group received daily injections of saline for 7 consecutive
days. The acute cocaine group received daily injections of saline for
6 days and an acute cocaine injection (15 mg ⁄ kg, i.p.) on Day 7. All
animals were transferred to an adjacent room to receive their daily
injections (at about 10:00 h) and were then returned to their colony
room. On Day 7 of cocaine administration, animals were either killed
45 min or 3 days (early abstinence; Garcia-Fuster et al., 2009)
following the last cocaine injection.
bLR ⁄ bHR differences in neurogenesis following
experimenter-administered cocaine
We used bLR ⁄ bHR rats (F20, n = 6 per phenotype per experimental
group) to determine the effects of experimenter-administered cocaine on
the different stages of adult HCal neurogenesis (Fig. 3A). The chosen
cellular markers enabled us to look back in time from the day of the
animal’s death and study cells born at different stages along the
sensitization process – i.e. new cells that proliferated immediately prior
to death, young immature neurons born partway through the sensitiza-
tion process, ormature neurons thatwere born prior to the first cocaine or
saline administration and survived and differentiated during the course
of the treatment. As depicted in Fig. 3, rats were pretreated for 3 days
with 5-bromo-2¢-deoxyuridine (BrdU; 50 mg ⁄ kg, i.p.; Calbiochem)
delivered at 12-h intervals 4 days before the treatment started (Thomas
et al., 2007). This protocol avoids marker dilution with cell division
(Dayer et al., 2003) and labels newly generated cells that will
differentiate, and after 28 days of survival (Brown et al., 2003) be
stably incorporated within the HC (Kempermann, 2002; Kempermann
et al., 2004). This enabled us to measure cocaine effects on late cell
survival (BrdU) and cell differentiation [BrdU ⁄ NeuN ⁄ glial fibrillary
acidic protein (GFAP)] separately from measures of recent cell
proliferation (Ki-67) and early cell survival (NeuroD) that can be
achieved with post mortem markers. Following the same paradigm as
described earlier, some bLR ⁄ bHR rats received injections of 15 mg ⁄ kg
cocaine (7 days, i.p.) whereas the control group received saline for seven
consecutive days (Fig. 3B). All animals were transferred to an adjacent
room to receive their daily injections (at about 10:00 h) and were then
returned to their colony room. On Day 7 of cocaine administration,
animals were either killed 45 min or 14 days (intermediate abstinence)
following the last cocaine injection. In an attempt to minimize the
number of animals used for the study, the control abstinence group was
not run due to the fact that we had observed no differences in
neurogenesis between the control group and the control abstinence
group (see Fig. 2, Results of previous experiment).
Tissue collection and IHC studies
At the times indicated above, animals were killed by decapitation and
the brains removed. The left half-brain was fast frozen and stored at
)80C until use for IHC experiments. For each animal, a series of
every 8th section was cryostat cut at 30 lm and slide-mounted
throughout the entire extent of the HC.
As mentioned earlier, we utilized molecular tools to examine at a
given point in time the effects of experimenter-administered cocaine
on cells at different stages of adult HCal neurogenesis within bLR
vs. bHR rats. Distinct cellular markers signified date of birth, thus
serving as an index of cocaine’s effects on recent cell generation,
early cell survival and late cell survival at the time of killing the
animals.
To determine the rate of recent cell proliferation, we performed IHC
labeling of Ki-67 (Figs 2 and 3), an intrinsic marker of ongoing cell
proliferation present during the active phases of the cell cycle (G1-M;
Scholzen & Gerdes, 2000; Kee et al., 2002). As described in detail by
Perez et al. (2009), sections were postfixed in 4% paraformaldehyde
(PFA) for 1 h, followed by 1 h incubation in 10% sodium citrate pH
6.0 at 90C for epitope retrieval. Sections were then rinsed with
phosphate-buffered saline (PBS), washed in 0.3% peroxide, blocked
with bovine serum albumin (BSA) containing 1% goat serum and
0.05% Triton X-100, and incubated overnight with polyclonal rabbit
anti-Ki-67 (1 : 40 000; University of Michigan). After PBS washes,
sections were incubated in biotinylated anti-rabbit secondary antibody
1 : 1000 (Vector Laboratories, Burlingame, CA, USA) followed by
Avidin ⁄ Biotin complex (Vectastain Elite ABC kit; Vectors Laborato-
ries) and diaminobenzidine (DAB) as chromogen.
The survival of developing neurons (cells born during the course of
the sensitization process) was visualized with the marker NeuroD
(Fig. 3), a transcription factor with a transient expression restricted to
cells as they become committed to a neuronal lineage during
differentiation within the DG in the HC (Lee, 1997; Miyata et al.,
1999; Amrein et al., 2004; Hevner et al., 2006). Sections were
postfixed in 4% PFA, incubated in endogenous peroxidase blocking
reagent (0.1% peroxide) and blocked with BSA containing 1% donkey
serum and 0.05% Triton X-100. Sections were then incubated
overnight with goat polyclonal anti-NeuroD (1 : 2500; Santa Cruz
Biotechnology). The next day, following PBS washes, sections were
incubated in biotinylated anti-goat secondary antibody 1 : 1000
(Vector Labs) followed by Avidin ⁄ Biotin complex and DAB reaction
with nickel chloride for visualization of signal.
The survival of cells born just prior to the sensitization process (rate
of late cell survival) was determined by labeling of BrdU (Fig. 3), a
synthetic thymidine analog that was injected before cocaine admin-
istration. BrdU is incorporated during the S-phase of the cell cycle into
newly synthesized DNA strands of actively proliferating cells
(Wojtowicz & Kee, 2006), and the number of these new cells that
survive throughout the treatment can then be measured at the end of
the study. Tissue was postfixed in 4% PFA for 1 h, rinsed in PBS and
washed in 0.3% peroxide. Sections were then incubated in 50%
formamide-50% 2· SSC at 65C for 2 h followed by rinses in 2·
SSC. Slides were placed for 30 min in 2N HCl at 37C for DNA
denaturation and 10 min in 0.1 m boric acid at room temperature
followed by rinsing in PBS and blocking with BSA. Sections were
incubated overnight with polyclonal anti-BrdU (1 : 20 000; Univer-
sity of Michigan) followed by anti-rabbit secondary antibody 1 : 1000
(Vector labs), Avidin ⁄ Biotin complex amplification and DAB reaction
for visualization of signal.
For all antibodies, controls were performed by blocking the specific
signal with the respective blocking peptide (data not shown). Cresyl
violet staining was performed for Ki-67 and BrdU protocols. All
sections were dehydrated through graded alcohols followed by
immersion in xylene and then coverslipped with Permount mounting
medium.
For determining the effects of cocaine treatments on cell differen-
tiation (phenotype of surviving cells) in the DG of the HC, we used
NeuN antibody to identify mature neurons (Mullen et al., 1992) and
GFAP antibody to label mature glial cells. Briefly, for fluorescent
triple labeling, following the same protocol as for BrdU labeling we
first incubated the sections overnight with a combination of polyclonal
anti-BrdU (1 : 20 000; University of Michigan) with monoclonal anti-
GFAP (1 : 1000; Millipore Bioscience Research Reagents). The next
day the sections were incubated with fluorescent secondary antibodies:
Alexa 594 goat anti-rat and Alexa-647 goat anti-mouse (Invitrogen).
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Fig. 3. Bred Low-Responder (bLR) ⁄ bred High-Responder (bHR) differences in adult HCal neurogenesis following experimenter-administered cocaine. (A) Stages
of adult HCal neurogenesis showing the molecular markers used to label each pool of cells: recent cell proliferation (Ki-67, cells born in the last 25 h); early cell
survival (NeuroD, approximately 4–10-day-old immature neurons); late cell survival and cell differentiation [5-bromo-2¢-deoxyuridine (BrdU), approximately
14–28-day-old mature neurons]. Figure adapted from Schmidt & Duman (2007). (B) Experimental design: bLR ⁄ bHR rats (F20, 18 pairs, n = 6 per group) were
pretreated for 3 days with BrdU delivery (50 mg ⁄ kg, i.p.) at 12-h intervals 4 days before the treatment began. Groups of treatment: vehicle (0.9% NaCl, i.p.,
7 days); chronic cocaine (15 mg ⁄ kg for 7 days); chronic cocaine followed by 14 days of abstinence. (C) Quantitative analysis of Ki-67-positive cells revealed a
decrease in cell proliferation following chronic cocaine in bLR rats. This effect persisted during the course of abstinence. (D) bHR rats showed no significant change
in cell proliferation following chronic cocaine. Note that 2 weeks of cocaine abstinence decreased cell proliferation by 26 ± 5% in the DG, although it did not reach
statistical significance. (E and F) Quantitative analysis of NeuroD-positive cells revealed no significant change in the number of short-term surviving cells in the DG
following cocaine treatments. (G) Quantitative analysis of BrdU-positive cells revealed no significant change in the number of long-term surviving cells in the DG
following cocaine treatments in bLR rats. (H) bHR rats showed cocaine abstinence-specific changes as measured by a decrease in the number of BrdU-positive cells
(28 days old) in the DG. Data are presented as the mean ± SEM. **P < 0.01 vs. vehicle; wP < 0.05 vs. chronic cocaine. GCL, granule cell layer; SGZ, subgranular
zone.
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For NeuN labeling, we used a primary monoclonal mouse anti-NeuN
antibody tagged with an Alexa 488 fluor (Millipore Bioscience
Research Reagents).
Cell counting
To ensure that a blind observer performed all cell counts for
quantifying Ki-67-, NeuroD- and BrdU-positive cells, slides were
initially coded and the code was not broken until counts were
analyzed. Thus, immunostained positive cells were counted with a
Leica DMR light microscope within the DG focusing through the
thickness of the section using a 63· oil objective. We used a modified
unbiased stereological procedure (Malberg & Duman, 2003) in which
every 8th section was counted throughout the extent of the HC, and
the sum was multiplied by the sampling factor 8 to provide an estimate
of the total number of positive cells per animal. In triple labeling
experiments, in order to determine the percentage of BrdU-positive
cells that co-labeled with NeuN or GFAP, we based our quantification
methodology on previous studies that followed the same procedures
and obtained reliable measures (Warner-Schmidt & Duman, 2007;
Perez et al., 2009) and examined at least 30 BrdU-positive cells per
subject using a laser-scanning confocal microscope (Olympus BX62).
Laser scans of 0.5-lm serial Z-section planes were visualized using a
63· oil objective. To obtain an estimate of the total number of new
neurons and new glial cells in the DG of each animal, the percentage
of BrdU-positive cells co-labeled with NeuN, GFAP or neither was
calculated and multiplied by the total number of BrdU-positive cells
for each animal.
Data and statistical analysis
All data were analyzed with GraphPad Prism, Version 5. Results are
expressed as mean values ± standard error of the mean (SEM). One-
way or two-way anova followed by a multiple comparison test
(Bonferrroni) and Student’s two-tailed t-test were used for the statistical
evaluations. The level of significance was chosen as P = 0.05.
Drugs and chemicals
Cocaine-HCl was obtained from Mallinckrodt (St Louis, MO, USA),
and BrdU was purchased from Calbiochem. Other materials were
purchased from Santa Cruz Biotechnology, Sigma-Aldrich and Vector
Laboratories.
Results
Study I: characterization of bLR and bHR rats
bLR ⁄ bHR differences in locomotor response to novelty
As shown in Fig. 1A, selective breeding across several generations
(F1–F20) produced a line of bHR rats, relative to bLR rats, that show
high levels of locomotion activity (lateral movement, rearing and total
activity, which is the sum of lateral and rearing movement) when
placed in a novel environment. By the 10th generation of breeding we
could predict with over 95% certainty the bLR or bHR classification of
our animals based on an animals’ parentage (i.e. ‡ 95% of bLR
offspring behaved reliably as bLRs, and ‡ 95% of bHR offspring
showed typical bHR behavior). Baseline differences in novelty-
induced locomotor activity dramatically diverged with increasing
rounds of selection (Fig. 1A). Note that for the present set of
experiments, we used bLR ⁄ bHR rats from generation 15 and 20 (F15,
F20), which clearly show marked basal differences in novelty-induced
motor activity, both lateral movement and rearing.
bLR ⁄ bHR differences in psychomotor sensitization to cocaine
As mentioned earlier, following bLR ⁄ bHR phenotype characterization
(Fig. 1A), we used seven pairs of adult bLR and bHR males from the
20th generation to ascertain bLR ⁄ bHR differences in psychomotor
sensitization to cocaine. Figure 1B shows the effects of repeated
cocaine administration and 14 days of cocaine abstinence on
locomotor activity on test days 1, 7 and 21 in bLR and bHR rats.
To analyze bLR and bHR differences in psychomotor response to
cocaine we first calculated the background levels of total locomotion
(last 30 min of habituation) for bLR (Day 1: 29 ± 9; Day 7: 14 ± 9;
Day 21: 56 ± 5) and bHR (Day 1: 494 ± 53; Day 7: 390 ± 64; Day
21: 530 ± 79) rats. We then used these background locomotion values
to correct the values post-cocaine stimulation for each phenotype,
providing the graphs shown in Fig. 1B. The same was done for lateral
(bLR, Day 1: 11 ± 4; Day 7: 4 ± 2; Day 21: 20 ± 3; and bHR, Day 1:
150 ± 23; Day 7: 120 ± 25; Day 21: 145 ± 26) and rearing locomo-
tion (bLR, Day 1: 18 ± 6; Day 7: 10 ± 7; Day 21: 36 ± 4; and bHR,
Day 1: 345 ± 38; Day 7: 270 ± 47; Day 21: 385 ± 63).
When analyzing total locomotion, two-way anova followed by
Bonferroni’s post hoc test revealed a significant effect of day
(F2,30 = 12.05, P = 0.0001) and group (F1,30 = 11.36, P = 0.0021),
with no interaction day · group (F2,30 = 0.54, P = 0.589). Post hoc
comparisons revealed a significant difference between groups after the
challenge dose at Day 21 (P < 0.05), with bHR rats showing increased
total locomotion compared with bLR rats. When lateral and rearing
locomotion were analyzed separately, two-way anova revealed the
following differences: lateral locomotion (effect of day, F2,30 = 9.09,
P = 0.0008; no group effect, F1,30 = 0.66, P = 0.424; no interaction,
F2,30 = 0.01, P = 0.989); and rearing locomotion (no day effect,
F2,30 = 2.23, P = 0.124; effect of group, F1,30 = 11.10, P = 0.0023;
no interaction, F2,30 = 0.63, P = 0.538). Post hoc comparisons
revealed a significant difference between groups only for rearing
locomotion after the challenge dose at Day 21 (P < 0.05), with bHR
rats showing increased rearing locomotion compared with bLR rats.
These results indicate that although both groups of animals exhibited a
certain degree of psychomotor sensitization to cocaine (e.g. Day 1 vs.
Day 21 for each phenotype when analyzing total and lateral
locomotion), the enhanced drug response seen in bHRs is mainly
driven by differences in rearing locomotion, a hallmark of sensitiza-
tion development (Szumlinski et al., 2003).
Study II: bLR ⁄ bHR differences in neurogenesis following
experimenter-administered cocaine
bLR ⁄ bHR differences in cell proliferation following
experimenter-administered cocaine
The effects of experimenter-administered cocaine on recent cell
proliferation (within a cell cycle time of 25 h; Cameron & McKay,
2001) as measured by Ki-67-positive cells in the DG was ascertained
in bLR ⁄ bHR rats (F15, n = 5 per phenotype per experimental group;
Fig. 2A). Note that two groups – Vehicle and Vehicle Abstinence –
were pooled as a single control group due to the lack of significant
differences in Ki-67-positive cell number between them (t-test: bLR,
F1,8 = 10.46, P = 0.19, n.s.; bHR, F1,8 = 1.76, P = 0.26, n.s.). As
shown in Fig. 2B and C, one-way anova detected a significant effect
of cocaine treatment only in bLR rats (anova followed by Bonfer-
roni’s test: LR rats: F3,21 = 3.247, P = 0.04; HR rats: F3,21 = 0.855,
P = 0.480, n.s.). Acute cocaine treatment did not alter cell prolifer-
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ation (bLR rats: 16 ± 12% increase, n.s.; bHR rats: 1 ± 14% change,
n.s.). However, after chronic cocaine treatment, cell proliferation was
decreased for both phenotypes, although it reached significance only
in the bLR animals (bLR rats: 32 ± 11% decrease, P < 0.05 when
compared with acute cocaine; bHR rats: 16 ± 8% decrease, n.s.). This
effect, although it lost significance, persisted after 3 days of abstinence
(bLR rats: 18 ± 14% decrease, n.s.; bHR rats: 20 ± 12% decrease,
n.s.). The results suggest that bLR and bHR animals exhibit different
patterns of cell proliferation as measured by Ki-67 cells in the DG,
with bLR rats being more reactive to the effects of cocaine on recent
cell proliferation.
bLR ⁄ bHR differences in neurogenesis following
experimenter-administered cocaine
bLR ⁄ bHR rats from the second cohort of animals (F20, n = 6 per
phenotype per experimental group) were used to examine the effects
of chronic cocaine exposure and 14 days cocaine abstinence on adult
HCal neurogenesis. As shown in Fig. 3 and described above, the three
measures quantified were: (i) cells that were recently born at the time
of killing the animals (in the last 25 h; recent cell proliferation);
(ii) cells born midway through the cocaine sensitization process (early
cell survival); and (iii) cells born at the beginning of the experiment
(approximately 14–28 days old; late cell survival).
Before analyzing the effects of cocaine on different stages of
neurogenesis, the basal rates of cells marked for each phenotype were
compared between vehicle-treated bLR and bHR groups. It should be
noted that as previously described in Perez et al. (2009), bLR ⁄ bHR
rats showed similar basal rates of cell proliferation as measured by
Ki-67 IHC (6 ± 9% difference; bLR: 8088 ± 547 vs. bHR: 8544 ±
748; P = 0.637), and a non-significant tendency to exhibit different
basal rates of early (19 ± 7% difference; bLR: 26 648 ± 1901 vs.
bHR: 31 653 ± 1766; P = 0.08) and late cell survival (16 ± 7%
difference; bLR: 10 547 ± 675 vs. bHR: 12 229 ± 705; P = 0.116).
The combination of data from the Ki-67, NeuroD and BrdU markers
(Fig. 3C–H) suggests that bLR and bHR lines tend to have some basal
differences in the turnover of adult-born cells in the HC, with bLRs
showing similar birth rates but lower rates of survival (Perez et al.,
2009).
When studying the effects of cocaine treatments on recent cell
proliferation in bLR rats, Ki-67 immunostaining revealed that chronic
cocaine reduced the number of Ki-67-positive cells in the DG by
26 ± 5% relative to the bLR vehicle treatment group, and this effect was
even greater (44 ± 6% decrease) after 14 days of abstinence (anova:
F2,15 = 13.52, P = 0.0004; Fig. 3C). For bHR rats, one-way anova
did not reveal significant changes (F2,15 = 3.072, P = 0.08; Fig. 3D) in
Ki-67 cell number in the DG following chronic cocaine (1 ± 12%
change) when compared with the bHR vehicle treatment group.
However, although it did not reach statistical significance, following
2 weeks of cocaine abstinence, recent cell proliferation was decreased
by 26 ± 5% in the DG of bHR rats. These results strengthen the
previous findings (F15 generation; Fig. 2B) and suggest that following
chronic cocaine treatments, bLR and bHR animals exhibit different
patterns of recent cell proliferation as measured by Ki-67 cell number in
the DG, with bLR rats showing a greater effect of cocaine on the rate of
cell birth (decreased after chronic cocaine and abstinence). Taken
together, the results show that chronic cocaine exposure has a negative
impact on recent cell proliferation in the DG of bLR rats.
To study the effects of experimenter-administered cocaine on the
survival of cells born midway through the sensitization process
(Fig. 3A), we examined NeuroD, a neuronal marker transiently
expressed by immature neurons (approximately 4–10 days of age). As
shown in Fig. 3E and F, quantitative analysis of NeuroD-positive cells
revealed no significant change in the number of young immature
neurons in the DG following cocaine treatments in bLR ⁄ bHR rats
(anova followed by Bonferroni’s test: bLR rats: F2,15 = 1.6,
P = 0.234, n.s.; bHR rats: F2,15 = 0.350, P = 0.71, n.s.). Therefore,
these results suggest that experimenter-administered cocaine did not
alter the survival of cells that were already born (young immature
neurons) at the time of killing the animals. This lack of effect suggests
that less mature cells may not respond to cocaine treatment because
they are a resistant cell population.
In order to study the effects of cocaine treatments on the survival of
cells born at the beginning of the experiment (late phase of cell
survival), BrdU (50 mg ⁄ kg, i.p., twice a day for 3 days) was
administered under basal conditions before the animals were exposed
to vehicle or cocaine (Fig. 3B; based on Thomas et al., 2007). The
animals were killed either 14 or 28 days after BrdU pretreatment.
Thus, determination of BrdU-positive cells in the DG yields a measure
of the impact of chronic exposure to cocaine, with or without
subsequent abstinence, on the survival rate of the cells born at the time
of BrdU labeling.
For bLR rats, Fig. 3G shows that BrdU incorporation in the DG did
not differ significantly between treatment groups (F2,15 = 0.858,
P = 0.444), suggesting that in bLRs cocaine did not compromise the
viability of the cells that were generated in the DG prior to treatment
and then exposed to cocaine. Interestingly, for bHR rats, we found that
the number of surviving BrdU-positive cells was reduced by 30 ± 8%
after 2 weeks of abstinence (28 days after BrdU labeling) following
chronic cocaine treatments (F2,15 = 7.256, P < 0.01 vs. vehicle,
P < 0.05 vs. chronic cocaine). Thus, bLR and bHR animals exhibited
different patterns of cell survival as measured by BrdU cell in the DG,
with bHR rats showing a main effect on the late phase of survival of
cells that were in the final stages of maturation during the course of
cocaine abstinence.
Given the differential response in late cell survival following
cocaine abstinence for bLR and bHR rats, we evaluated the pattern of
cell differentiation of the surviving BrdU-labeled cells and obtained an
estimate of the total number of neurons and astrocytes generated in the
DG. As detailed in Fig. 4A, injections of BrdU were administered
28 days before animals were killed, providing us with a measure of the
survival rate of the cells born at the time of BrdU labeling and
showing us possible effects of cocaine abstinence on basal neurogen-
esis. Such a protocol allows the follow-up of newborn cells with the
analysis of their maturation dynamics and the process of phenotype
acquisition. Figure 4B illustrates that the large majority of newborn
BrdU-positive cells in the DG expressed the neuronal marker NeuN
(bLR, 91.7 ± 2.6%; bHR, 92.9 ± 1.4%), whereas a minority was
either double labeled with GFAP, an astroglial marker (bLR,
3.8 ± 1.7%; bHR, 4.6 ± 1.4%), or not identified (bLR, 4.6 ± 1.5%;
bHR, 2.5 ± 0.9%). These ratios were not significantly different
between groups (NeuN, F1,10 = 1.088, P = 0.766; GFAP,
F1,10 = 1.440, P = 0.585; Neither, F1,10 = 2.531, P = 0.215). These
results show that the difference in late cell survival shown by bLR and
bHR rats following cocaine abstinence did not correlate with a change
in their maturation dynamics, as most of the surviving cells expressed
the neuronal phenotype. It is therefore tempting to speculate that the
decrease in late cell survival (mature cells, 28 days old) observed for
bHR rats might translate in a decrease in mature neurons in the DG.
Discussion
The present findings provide a detailed characterization of cocaine’s
effect on adult HCal neurogenesis in rats selectively bred for low
(bLR) vs. high (bHR) novelty-seeking behavior. In general, cocaine
Cocaine sensitization and neurogenesis in bLR ⁄ bHRs 85
ª The Authors (2009). Journal Compilation ª Federation of European Neuroscience Societies and Blackwell Publishing Ltd
European Journal of Neuroscience, 31, 79–89
decreased HCal neurogenesis in both groups but at different control
points. bLR rats primarily showed an effect of chronic cocaine and
cocaine abstinence on cell proliferation, with no apparent impact on
the survival or differentiation of preexisting adult stem cells.
Moreover, this effect appears to become amplified over time,
exhibiting a steady decrease in proliferation from acute to chronic
cocaine exposure, and from chronic exposure to abstinence. By
contrast, bHR rats exhibited abstinence-specific changes in the late
survival of cells that were born under basal conditions before the
cocaine treatment was initiated.
Specifically, the results for Study I regarding the characterization of
the bLR ⁄ bHR animal model showed that: (i) selective breeding for the
novelty-seeking trait across generations produced a line of bHR rats
that show high levels of locomotion compared with their bLR
counterparts; and (ii) the enhanced psychomotor response to cocaine
seen in bHR rats is mainly driven by differences in rearing
locomotion, a hallmark of sensitization development. For Study II,
regarding the differential effects of cocaine on adult HCal neurogen-
esis in bLR ⁄ bHR rats, we showed the following. (i) Acute cocaine
administration did not alter recent cell proliferation as measured by
Ki-67-positive cells in the DG of either bLR or bHR rats. (ii) Repeated
cocaine administration induced a decrease in cell proliferation, an
effect only seen in bLR rats, which persisted and became amplified
through the course of abstinence (14 days). This effect was replicated
in two separate generations of bLR ⁄ bHR rats (F15 and F20) in
separate sets of experiments. (iii) Neither chronic cocaine administra-
tion nor cocaine abstinence affected the survival of cells born midway
through the sensitization process and expressing a marker of immature
neurons (NeuroD) both in bLR and bHR rats. (iv) Cocaine abstinence
was associated with decreased survival of adult mature neurons
Fig. 4. Effect of cocaine abstinence on cell differentiation of adult-born cells in the DG of bred Low-Responder (bLR) ⁄ bred High-Responder (bHR) rats. (A)
Experimental design. (B) Data are presented as the mean ± SEM. The large majority of the newborn 5-bromo-2¢-deoxyuridine (BrdU)-positive cells in the DG
expressed the neuronal marker NeuN (bLR, 91.7 ± 2.6%; bHR, 92.9 ± 1.4%), whereas a minority was either double labeled with glial fibrillary acidic protein
(GFAP), an astroglial marker (bLR, 3.8 ± 1.7%; bHR, 4.6 ± 1.4%) or not identified (bLR, 4.6 ± 1.5%; bHR, 2.5 ± 0.9%). These ratios were not significantly
different between groups. (C) Representative confocal images of BrdU (red labeling), NeuN (green labeling) and GFAP (blue labeling). The merged image, BrdU-
labeled cell co-labeled with NeuN (merge) was confirmed in the x, y ⁄ x, z axis (scale bar, 10 lm), and included eight optical sections. Voxel size
(x = 0.265 lm ⁄ pixel; y = 0.265 lm ⁄ pixel; z = 0.44 lm ⁄ pixel).
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specifically in bHR rats. These cells were born under basal conditions
before the cocaine treatment started and were 28 days old when the
animals were killed. (v) The course of treatment did not affect the ratio
of neurons to glia in either bLR or bHR, with most of the surviving
cells acquiring the neuronal phenotype.
The LR–HR rat model provides a useful tool to examine potential
molecular mechanisms that underlie their differential behavioral
response to cocaine although, notably, the LR ⁄ HR trait does not
appear to predict the transition to compulsive drug use (see Belin
et al., 2008). Among other differences in drug-seeking behavior,
commercially available (non-selectively bred) HR rats will self-
administer psychostimulants more readily than their LR counterparts
(Piazza et al., 1989; Piazza & Le Moal, 1996) and will display
exaggerated behavioral sensitization to these drugs (Hooks et al.,
1991, 1992). Consistent with these studies in commercially available
LR ⁄ HR rats, selective breeding has amplified many of the differences
seen in commercially available LR ⁄ HR animals that appear directly
relevant to the enhanced differences in initial propensity to drug abuse.
In this line, bHRs acquired cocaine self-administration more rapidly
than bLR rats (Davis et al., 2008). Moreover, a recent study from our
lab (Waselus et al., 2009) examined multiple measures indicative of
behavioral sensitization (i.e. locomotion, darting, immobility, left–
right head movements and rearing) to identify differences between
cocaine-treated bHR and bLR rats. Similar to our results, the study
demonstrated that while both phenotypes showed evidence of
sensitization, bHRs exhibited an enhanced drug response. Along
these lines, our differences in motor response were mainly driven by
changes in rearing locomotion, which has been described as a
landmark of cocaine sensitization (Szumlinski et al., 2003).
After demonstrating the bLR ⁄ bHR differences in cocaine-induced
psychomotor sensitization we examined adult HCal neurogenesis as a
potential molecular mechanism differentially altered by cocaine within
each phenotype. Note that individual correlations between the
behavioral (i.e. psychomotor response to cocaine) and the molecular
data (i.e. neurogenesis) were not assessed because these experiments
were performed in separate groups of rats. However, the experiments
were run in parallel to ensure that brains assessed for possible
neurogenesis changes were exposed to an identical cocaine treatment
regimen known to evoke psychomotor differences in bLR ⁄ bHR rats.
When studying neurogenesis, it is critical to establish adequate
protocols to appropriately distinguish dividing cells such that cell
proliferation and cell survival can be clearly differentiated. The present
study evaluated the impact of cocaine on cells born at different time
points, i.e. cells at different stages of maturation along the neurogen-
esis process when the animals were killed. Ki-67 was used to mark
recently divided cells (Scholzen & Gerdes, 2000; Kee et al., 2002);
NeuroD indicated immature young neurons (von Bohlen Und
Halbach, 2007); and BrdU demarcated mature cells (Dayer et al.,
2003; Thomas et al., 2007) that differentiated into glial, neuronal or an
undefined cell type. Remarkably, it has been recently described that
Ki-67 and NeuroD do not colocalize in the same population of cells
(Larsen et al., 2007), and that Ki-67 and BrdU only colocalize from
2 h until 4 days post-BrdU injection (Dayer et al., 2003). This
indicates that new BrdU-labeled daughter cells are added throughout
this period of approximately four cell cycles (see Fig. 3 for
experimental design), and that cell proliferation and survival can be
clearly differentiated using these two molecular markers. Moreover, as
no co-localization of NeuroD was observed following 14 and 28 days
of BrdU injections (Kawai et al., 2004), these molecular markers
allowed us to study the effects of early and late cell survival separately.
Our results showed that for bLR rats, repetitive but not single
administration of cocaine decreased cell proliferation as measured by
Ki-67-positive cells in adult rat HC without influencing cell survival
and cell differentiation. Thus, experimenter-administered cocaine in
bLR rats affected different cell populations depending on their stage of
maturity along the neurogenesis process; specifically, cocaine appears
to decrease the rate of cell birth and proliferation without altering the
maturation of cells that were already born at the time of killing the
animals (i.e. NeuroD-positive immature neurons and BrdU-positive
mature neurons). Similar results were previously described for
commercially available Sprague–Dawley rats (Yamaguchi et al.,
2004; Dominguez-Escriba et al., 2006). Indeed, newborn cells could
be undergoing plasticity changes before they reach full maturity, and
their functions may well be different from those of mature granule
neurons (Canales, 2007). It is believed that the adult DG only has a
limited supply of dividing progenitor cells (von Bohlen Und Halbach,
2007); thus, decreased cell proliferation might reflect a direct action of
cocaine on the progenitor cell population (Eisch & Harburg, 2006),
leading to a cessation, reduction or otherwise alteration of cell cycle
division, or perhaps enhanced cell death. Furthermore, decreased cell
proliferation might also lead to a delayed reduction of cell survival, i.e.
less cell birth giving rise to a lesser number of mature neurons. Or, as
described by Noonan et al. (2008), the effects of cocaine administra-
tion on cell proliferation may become evident in a later change in their
maturity. Future experiments will address these hypotheses by
administering BrdU immediately before the end of the abstinence
period and assessing cocaine effects on cell maturation and cell
survival (14–28 days later).
On the other end, for bHR rats, experimenter administration of
cocaine (acute and chronic) did not affect the rate of recent cell
proliferation (cell birth during the last cell cycle, 25 h), and did not
influence the survival of cells born halfway (immature neurons) or at
the beginning of the sensitization process (mature neurons). However,
during the course of abstinence, there were specific changes in bHR
rats, i.e. a 26% non-significant decrease in the rate of cell birth but,
most importantly, a decrease in the number of mature surviving
neurons when compared with vehicle or chronic cocaine groups.
Notably, the survival of immature cells labeled with NeuroD was not
compromised following cocaine abstinence. It has previously been
shown that distinct populations of cells in the adult DG will respond to
certain stimulus depending on the cell’s age at the time of exposure to
the stimulus (Cameron & Gould, 1996). An important thing to
remember when studying the regulation of neurogenesis is that the
generation of new neurons is the end product of a series of steps
consisting of cell proliferation, survival, migration, differentiation and
establishment of functional connections with other neurons (Lledo
et al., 2006). Having this in mind, the results showed that during
abstinence to chronic cocaine, bHR rats appeared to have a critical
window of neurogenesis regulation from immature neurons to mature
integrated neurons in which the number of surviving mature neurons is
decreased, possibly due to more cell death. The critical time-point in
postnatal cell genesis when the decision toward neuronal differenti-
ation is made and the crucial restriction ‘point of no return’ is reached
remains unclear (von Bohlen Und Halbach, 2007). Our results suggest
that in the context of cocaine sensitization, in bHR rats, the critical
window of neurogenesis regulation occurs during abstinence at the
level of decreasing the number of functionally mature neurons.
Interestingly, this window of decreased neurogenesis regulation
parallels the time when bLR and bHR rats show distinct psychomotor
responses to cocaine, with bHR rats exhibiting greater drug-induced
rearing locomotion. Thus, it is reasonable to hypothesize that the
regulation of adult HCal neurogenesis may be involved in the
emergence of certain symptoms manifested during psychomotor
sensitization. More importantly, our results support the idea previously
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described by Chambers & Taylor (2004), which associated an
impairment of HCal function with a higher behavioral sensitization
to cocaine. In the present study, the impairment of HCal function was
manifested as a decrease in the number of mature neurons (lesser
connections in the circuitry) in conjunction with a greater psychomo-
tor response to cocaine in bHR rats. Other studies also showed that
adult neurogenesis plays an important role in HCal function (Cameron
& McKay, 2001), and specifically in drug-taking and drug-seeking
behaviors via its projections to the reward-related limbic regions
(Taepavarapruk et al., 2000; Canales, 2007).
To conclude, the present results suggest that bLR and bHR rat
brains react differently to drugs of abuse, with each selectively-bred
line exhibiting a distinct psychomotor response to cocaine, and
showing different patterns and time-points of neurogenesis regulation
following experimenter-administered cocaine. Indeed, cocaine targets
different populations of cells in bLR ⁄ bHR rats: the progenitor neural
stem cells causing decreased birth of new cells in bLR rats; and the
number of mature neurons in bHR rats. Several factors could account
for this differential regulation. For example, the absence of
bLR ⁄ bHR behavioral differences after chronic cocaine and their
obvious difference in cell proliferation could be due to a disconnec-
tion between these factors and a connection between other factors
known to differ in bLR ⁄ bHR (e.g. Perez et al., 2009) and the
manifestation of changes in cell proliferation. Another important
aspect to consider involves a matter of timing; less cell birth in bLR
rats will eventually lead to a decreased number of mature neurons,
suggesting a delayed effect over neurogenesis regulation, and
reaffirming the delayed or blunted response to drugs of abuse
apparent for bLR vs. bHR animals. The exact role of new neurons in
adult HCal function remains unknown, but it is tempting to speculate
that the earlier decrease in new functional connections in bHR rats
could contribute, at least in part, to their enhanced psychomotor
response following chronic cocaine administration. These results
support the growing literature regarding altered neurogenesis as one
drug-regulated form of plasticity. Moreover, the use of selective
breeding highlights the importance of identifying the neuroadapta-
tions that might confer enhanced drug responses, because they might
help develop novel and better-tailored treatment options. Thus, in
future studies it will be of great interest to ascertain how
neurogenesis is differentially regulated in bLR and bHR rats when
exposed to a paradigm of long-term addiction (i.e. extended access
cocaine self-administration).
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